An expert advisory board under the FDA medical regulator has recommended Johnson & Johnson's COVID-19 vaccine for use in the United States, Report informs referring to RIA Novosti.
This is evidenced by the results of the council's voting.
The FDA is expected to approve the vaccine for emergency use as early as Feb. 27.
In this case, three coronavirus vaccines will already be used in the US, the other two produced by Pfizer and Moderna.
The experts of the advisory board unanimously ruled that the potential benefits of the vaccine outweigh the potential risks.
Unlike other US-approved vaccines, this one requires only one shot, not two.